Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study

The objective of this study was to evaluate the real-world application, efficacy, and safety data of olaparib for maintenance therapy and active treatment in patients with ovarian cancer in China. Patients with ovarian cancer from 17 institutions in China treated with olaparib as maintenance or acti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular cancer therapeutics 2021-09, Vol.20 (9), p.1735-1742
Hauptverfasser:	Zheng, Hong, Gao, Yunong, Guo, Hongyan, Li, Li, Li, Qingshui, Cui, Heng, Lin, An, Sun, Lixin, Hu, Yuanjing, Kang, Shan, Duan, Wei, Pan, Lingya, Wang, Shuzhen, Yang, Yingjie, Li, Yunxia, Kong, Weimin, Xiang, Yang, Tian, Xiaofei, Ling, Bin, Ha, Chunfang, Bai, Wenpei
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Female Follow-Up Studies Humans Middle Aged Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Phthalazines - therapeutic use Piperazines - therapeutic use Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use Prognosis Retrospective Studies Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!